TIDMAMS

RNS Number : 5105C

Advanced Medical Solutions Grp PLC

13 April 2017

 
 
     13 April 2017

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Director/PDMR and PCA Shareholding

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, announces that it was notified on 11 April 2017 that Jeff Willis, who is a Senior Manager and PDMR, had sold 100,000 Ordinary Shares of 5p on 10 April 2017.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial 
       responsibilities/person closely associated 
---  -------------------------------------------------- 
 a)   Name: Jeff Willis 
---  -------------------------------------------------- 
 2.   Reason for the notification 
---  -------------------------------------------------- 
 a)   Position/status: PDMR 
---  -------------------------------------------------- 
 b)   Initial notification/Amendment: Initial 
       Notification 
---  -------------------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  -------------------------------------------------- 
 a)   Name: Advanced Medical Solutions Group 
       plc 
---  -------------------------------------------------- 
 b)   LEI: 213800HJP6OWOSZI1L74 
---  -------------------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  -------------------------------------------------- 
 a)   Description of the financial instrument, 
       type of instrument: Ordinary Shares of 
       5p 
       Identification code: GB0004536594 
---  -------------------------------------------------- 
 b)      Nature of the transactions: 
           *    Sale of 100,000 Ordinary Shares of 5p 
---  -------------------------------------------------- 
 c)   Price(s) and volume(s): 
       Sale of shares: Price(s)     Volume(s) 
       -----------  ---------- 
        GBP2.6025    100,000 
       -----------  ---------- 
---  -------------------------------------------------- 
 d)   Aggregated information: (Relates to those 
       shares sold only) 
       Aggregated volume: 100,000 
       Aggregated price: GBP2.6025 
---  -------------------------------------------------- 
 e)   Date of the transaction: 10/04/2017 
---  -------------------------------------------------- 
 f)   Place of the transaction: London Stock 
       Exchange, AIM Market (XLON) 
---  --------------------------------------------------

- End -

For further information, please visit www.admedsol.com or contact:

 
 Advanced Medical Solutions Group                Tel: +44 (0) 
  plc                                             1606 545508 
 Chris Meredith, Chief Executive 
  Officer 
  Mary Tavener, Chief Financial 
  Officer 
 
 Consilium Strategic Communications              Tel: +44 (0) 
                                                 20 3709 5700 
 Mary-Jane Elliott / Jonathan         AMS@consilium-comms.com 
  Birt / Matthew Neal / Hendrik 
  Thys 
 
 Investec Bank plc (NOMAD & Broker)              Tel: +44 (0) 
                                                 20 7597 5970 
 Daniel Adams / Patrick Robb

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal(R) , and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand(R) and RESORBA(R) .

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Company has 600 employees. For more information, please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBLGDSLDBBGRX

(END) Dow Jones Newswires

April 13, 2017 12:30 ET (16:30 GMT)

Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Advanced Medical Solutions Charts.